1) Phase III Trial Comparing Intensive Induction Chemoradiotherapy (60 Gy, Infusional 5-FU and Intermittent Cisplatin) Followed by Maintenance Gemcitabine with Gemcitabine Alone for Locally Advanced Unresectable Pancreatic Cancer. Definitive Results of the 2000–01 FFCD/SFRO Study. Chauffert, B, Mornex,F, Bonnetain,F, et al. Annals of Oncology. 2008; 19: 1592-1599.

2) Treatment of Locally Advanced Pancreatic Cancer:  The Role of Radiation Therapy Johung, K,  Saif, MW, and Chang, BW. International Journal of Radiation Oncology Biology Physics. 2012; 82(2):508-518.